How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Outbreaks News Archives

Login / Signup

Early Release – Increasing Predominance of Norovirus GII.17 over GII.4, United States, 2022–2025 – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Rapid Emergence and Evolution of SARS-CoV-2 Intrahost Variants among COVID-19 Patients with Prolonged Infections, Singapore – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Evidence of Viremia in Dairy Cows Naturally Infected with Influenza A Virus, California, USA – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Human Streptococcus suis Infections, South America, 1995–2024 – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Emerging Infections Network Survey of Screening for Cryptococcal Antigenemia, United States, 2024 – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Communicable disease threats report, 24-30 May 2025, week 22

Early Release – Genomic Deletion of PfHRP2 and PfHRP3 Antigens in Plasmodium falciparum Strains, Ethiopia, 2009 – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Clinical Manifestations, Risk Factors, and Disease Burden of Rickettsiosis, Cambodia, 2007–2020 – Volume 31, Number 6—June 2025 – Emerging Infectious Diseases journal

Communicable disease threats report, 17-23 May 2025, week 21

Early Release – Aedes aegypti Mosquito Detection at Bus Stations, Bogota, Colombia, 2023–2024 – Volume 31, Number 6—June 2025 – Emerging Infectious Diseases journal

Schedule an Appointment

Quick Links

Patient Forms

Contact Us